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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not PRP
injections are more effective in decreasing chronic lower back pain as compared to epidural
injections in young adults.
Study Design: Systematic review of three English language randomized controlled trials (RCTs),
all published after 2012.
Data Sources: Two double-blind RCTs and one randomized open blinded end point (PROBE),
which analyzed the effectiveness of PRP and epidural injections in young adults with chronic
lower back pain. All studies were found using PubMed.
Outcome(s) Measured: Each of the articles analyzed the pain relief and function ability stated by
the patient post PRP injections and epidural injections. These outcomes were measured using the
visual analog scale score (VAS), the average of Numeric Rating Scale (NRS), the Oswestry
Disability Index (ODI), the Modified Oswestry Disability questionnaire (MODQ), and the
Functional Rating Index (FRI). Significance was determined using p-values for all three studies.
Results: Manchikanti et al. (2014) found that there was no significant difference between the use
of local anesthetic alone compared to local anesthetic and steroid when treating chronic lower
back pain in regards to pain and function measured by NRS and ODI scores. Singla et al. (2017)
found that the pain significantly decreased at 6 weeks in patients treated with PRP injections
compared to the group treated with steroid injections. This study also showed that the efficacy of
PRP injections at 3 months was 90% compared to only 25% in the group with steroid injections.
Tuakli-Wosornu et al. (2016) found that patients treated with PRP injections showed statistically
significant improvements in pain and function 8 weeks post-procedure in regards to NRS best
pain and FRI score.
Conclusions: the results from the three randomized controlled studies demonstrated that PRP
injections are more effective in decreasing chronic lower back pain compared to epidural steroid
injections by having less procedures, less adverse effects and providing lasting pain relief.
Key words: chronic lower back pain, platelet rich plasma, steroid injections.
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INTRODUCTION
Low back pain is a very common condition in adults. Approximately, 80% of adults
experience at least one episode of low back pain during their lifetime and approximately 20% of
these patients have another episode within six months.1 According to the National Institute of
Neurological Disorders and Stroke “back pain is caused by general degeneration of the spine
associated with normal wear and tear that occurs in the joints, discs, and bones of the spine as
people get older” The cause of low back pain is very complex, although the most common cause
is degenerative changes in the lumbar spine.2
This condition is the most common cause of disability among Americans between 45 and
65 years of age;1 and it is the second most common cause of primary care visits.3 The cost of
lumbar epidural steroid transforaminal treatment based on setting arrangement is between $2,600
to $3,000 per year.1 Therefore making it difficult for patients who do not have health insurance
coverage to afford these treatments. Today, low back pain is estimated to be the third largest
condition of health care spending at $87.6 billion.4
Aside from plasma rich platelet injections there are several non-invasive methods to treat
low back pain such as acupuncture, physical therapy, physiotherapy, NSAIDs and opioids. In
addition, there are other treatments that are more invasive such as radiofrequency neurotomy,
epidural steroid injections, and if all these fail, then surgery. The three studies that will be
discussed are recent RCTs that evaluate the efficacy of plasma rich platelet injections compared
to epidural steroid injections.
Plasma rich platelets (PRP) is a biological blood-derived product that can be injected to
various tissues since it releases high concentrations of platelet-derived growth factors that
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enhance the body’s natural healing process.2 However, there is very little research on the topic
due to the lack of standardization of graft preparation. 3
OBJECTIVE
The objective of this selective EBM review is to determine whether or not PRP injections
are more effective in decreasing chronic lower back pain as compared to epidural injections in
young adults.
METHODS
All three articles were obtained via a search of the PubMed database using the keywords
chronic lower back pain, platelet rich plasma, and steroid injections. Only randomized control
trials published after 2012 were selected, based on the relevance and the importance of outcome
to the patient. The articles chosen were published in English in peer-reviewed journals. Inclusion
criteria included randomized controlled trial prospective studies; and they included patients who
were at least 18 years old with chronic lower back pain for more than three months treated with
either PRP or steroids injections in the lumbar area below L3. Exclusion criteria included
patients who used PRP in another joints or tissues.
This review is comprised of a set of three randomized controlled trials that were selected
based on relevance and patient oriented evidence that matter (POEMs). Manchikanti et al.1 used
a RCT double blind study to compare two groups. Group I received lidocaine and a sodium
chloride solution while group II received lidocaine plus betamethasone. The outcomes measured
were pain relief and functional status using Numeric Rating Scale (NRS) and the Oswestry
Disability Index (ODI). Singla et al.2 used a prospective randomized open blinded end-point
study (PROBE) to compare two groups. Group S received methylprednisolone and lidocaine
while group P received leukocyte-free PRP and calcium chloride. The outcomes measured were
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intensity of pain and functional disability with visual analog scale (VAS) and Modified Oswestry
Disability Questionnaire (MODQ). Tuakli-Wosornu et al.3 used a double-blind RCT to compare
intradiscal PRP injections vs. a contrast agent. The outcomes measured were improvement in
pain and function with Functional Rating Index (FRI) and Numeric Rating Scale (NRS). All
three of the studies determined significance using p-values.1,2,3 A summary of the demographics
of each study can be found in Table 1 below.
Table 1: Demographics and Characteristics of Included Studies.
STUDY

TYPE

#
PTS

AGE
(yrs)

Inclusion criteria

Exclusion criteria

W
/D

Interventions

Manchika
nti, 20141

Double
blind
RCT

120

43 ±
12
years

- Pts who were at least
18 y/o with chronic
lower back pain and
lower extremity pain of
at least 6 months, only
disc herniations at L4L5 and L5-S1, all pts
must have PT along with
exercise program and
nonsteroidal antiinflammatory therapy.

- Hx of previous lumbar
surgery, radiculitis w/o
disc herniations, pts
with B/L radiculopathy,
radiculitis secondary to
spinal stenosis, and pts
with other uncontrolled
medical illnesses.

0

Group 1
received local
anesthetic with
saline whereas
pts in group 2
received local
anesthetic and
steroid.

Singla,
20172

Open
blind
RCT

40

18-65

- Pts of either sex with
chronic low back pain
(predominantly below
the L5 vertebra) of
moderate intensity for >
3 months, Pts having
unilateral SIJ pathology
on X-ray, magnetic
Patients having
unilateral SIJ pathology
on X-ray, MRI, or
nuclear scan with 3 or
more positive
provocative tests.

- Systemic infection or
localized infection at
the anticipated
introducer entry site,
spinal pathology that
may impede recovery,
pregnancy, Active
radicular pain,
Immunosuppressive
conditions, allergy to
medications used in the
procedure; narcotic use,
contraindications
pertaining to the use of
platelet concentrate.

0

A mixture of
2% lidocaine
with
methylprednisol
one or PRP with
calcium
chloride.

TuakliWosornu,
20163

Double
blind
RCT

51

44 ±
9
years

- Refractory low back
pain persisting for > 6
months, failure of
conservative treatment
measures, maintained
intervertebral disk height
of at least 50%, disk

- Presence of a known
bleeding disorder,
current anticoagulation
therapy ,pregnancy ,
systemic or skin
infection over the
puncture site, allergy to

4

A single
Intradiscal PRP
injection vs.
visualized
matched
placebo

Leones, PRP and steroid injections 5

protrusion less than 2
mm on MRI or CT,
concordant pain on
discography, presence of
a grade 3 or 4 annular
fissure as determined by
discography, Absent
contraindications (eg,
spinal stenosis)

contrast agent, presence
of a psychiatric
condition, solid bone
fusion preventing
access to the disk,
severe spinal canal
compromise at the
levels to be
investigated, extrusions
or sequestered disk
fragments, previous
spinal surgery,
spondylolysis,
spondylolisthesis.

OUTCOMES MEASURED
The outcomes measured in each of the three studies were functional ability and back pain
relief. Both are considered patient-oriented outcomes because they significantly impacted a
patient’s quality of life. Manchikanti et al. measured pain with the Numeric Rating Scale (NRS)
and also measured functional ability with the Oswestry Disability Index (ODI).1 These were
measured at 3,6,12,18, and 24 months. This study also measured secondary outcomes such as
opioid intake, employment, and work status among both groups, but were not examined in this
review.
Singla et al. measured the pain intensity with the visual analog scale (VAS) from preinjection to follow-ups in both groups at 2,4,6 weeks and 3 months.2 The disability of the patient
was measured by Modified Oswestry Disability Questionnaire (MODQ) score. These were also
measured at 2,4,6 weeks and 3 months. This study also compared post-injection complications
among both groups, but these were not examined in this review.
Tuakli-Wosornu et al. measured function and pain related with Functional Rating Index
(FRI) and Numeric Rating Scale (NRS).3 This study also measured secondary outcomes among
both groups, but these were not examined in this review.

Leones, PRP and steroid injections 6

RESULTS
In the study by Manchikanti et al.1, 120 patients with chronic low back pain and with disc
herniations at levels L4-L5 and L5-S1 were enrolled. Patients were assigned randomly via
computer to two groups with 60 patients in each group: Group I was treated with 1.5 ml of
preservative-free lidocaine 1% followed by a 0.5 ml sodium chloride solution, while group II
was treated with preservative-free lidocaine 1% followed by 3 ml of betamethasone. All patients
continued drug therapy with opioids or nonsteroidal anti-inflammatory drugs at a lower dose. All
the injections were performed by one physician in an interventional pain management center
based on Consolidated Standards Reporting Trials (CONSORT) guidance. An intention to treat
analysis was used when data was missing or unavailable. At baseline, both groups had similar
clinical characteristics with no statistical differences regarding the NRS and ODI as described in
table 2. This study showed that there is no superiority from using steroids injections over
lidocaine injections for low back pain. Both showed significant and similar improvement of at
least 50% in pain and function in responsive patients. In addition, at 2 years, 65% of patients
who received lidocaine alone showed improvement in comparison to 57% who received steroids.
Table 2: Comparison of NRS and ODI at baseline and at 2 years.
Time Points

Numeric Pain Rating Scale

Oswestry Disability Index

Group I
Mean ± SD

Group II
Mean ± SD

Group I
Mean ± SD

Group II
Mean ± SD

Baseline

8.3 ± 0.9

8.2 ± 0.9

29.9 ± 4.8

28.0 ± 5.3

24 months

4.0* ± 1.6

4.2* ± 1.6

14.9* ± 6.9

14.1* ± 6.5

* significant difference with baseline values within the group (P <0.001)
Manchikanti et al. Transforaminal epidural injections in chronic lumbar disc herniation - a
randomized, double blind, active control trial.
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Table 3: Efficacy of lidocaine injections compared lidocaine with steroid injections at 2 years.
CER

EER

RBI

ABI

NNT

0.7

0.6

-0.14

-0.01

-10

Local adverse events including 28 (4.6%) intravascular infiltrations and 9 (1.5%) nerve
root irritations were obtained during the entire the study.
In the study by Singla et al.,2 forty patients were selected who met the criteria between
the ages of 18 and 65 years old with chronic low back pain predominantly below L5. Patients
were assigned randomly via computer to two groups with 20 patients in each group. Group S was
treated with 1.5 ml of methylprednisolone and 1.5 ml of 2% lidocaine with 0.5 ml of saline,
while Group P received 3 ml of leukocyte-free PRP with 0.5 ml of calcium chloride. All pain
medications were discontinued, including NSAIDs, before the start of this study. The injections
were administered only once and patients followed up at 2,4,6 weeks and 3 months. Data
analysis was performed using Statistical Package for the Social Sciences version 20. All tests
were evaluated for 95% confidence limits. A P-value of less than 0.05 was considered as
statistically significant. At the baseline parameters, both groups had similar clinical
characteristics with no statistical differences regarding the VAS score, this held true at both 2
weeks and 4 weeks according to the study. At three months, the percentage of pain free in group
P was 90% compared to 25% in group S. The MODQ scores were very similar in both groups at
pre-injection, 2 weeks and 4 weeks; however, at 6 weeks and 3 months it was much lower in
Group P compared to Group S as expressed in this article. No major post-injections
complications were reported in any of the groups other than temporary pain and stiffness in
Group P that subsided within 2 days of onset. The odds of achieving reduction in VAS >50%
from baseline in group P were 10.91 times higher than in group S at 6 weeks, and 37.28 times
higher at 3 months as described in table 5.2
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Table 4: Efficacy of PRP injections compared to steroid injections at 3 months.
CER

EER

RBI

ABI

NNT

P-value

0.3

0.9

2.6

-0.67

2

0.01

Table 5: Patients with reduction of VAS at different times (pain reduction) and MODQ (disability)
Time Points

VAS

MODQ

Group P

Group S

2 weeks

12 (60 %)

15 (75%)

3 months

18 (90 %)

5 (25 %)

Group P

Group S

Baseline

48 %

45 %

3 months

28 %

14 %

Pvalue

95 % CI

0.001

27.0 –
159.66

In the study by Tuakli-Wosornu et al.,3 forty-seven patients were studied who had
refractory low back pain for longer than 6 months with the presence of grade 3 or 4 annular
fissure (< 2ml) seen in discography. The treatment group included 29 participants while the
control group included 18 participants. The treatment group received 3-4 ml of PRP while the
control group received 1-2 ml of contrast agent. A P-value of less than 0.05 was considered as
statistically significant. These injections were administered only once and patients were analyzed
at baseline, 1 week, 4 weeks, and 8 weeks. In addition, twenty eight patients came back at 6
months for follow up and 21 patients came back a year later for a last follow up. At baseline
there was no significant difference between both groups. At the 8 week follow up, the
comparisons between both groups demonstrated significant improvement in the PRP group
compared to the control group regarding the FRI score (P= 0.03) and the NRS (P=0.02). Fifty
six percent of the patients treated with PRP were satisfied with the treatment compared to 18% of
the patients in the control group. No complications were reported in either group.
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Table 6: Efficacy of PRP injections compared to placebo group at 8 weeks.
CER

EER

RBI

ABI

NNT

P-value

0.18

0.56

2.1

0.38

3

0.01

Table 7: Comparison of NRS (best pain) and FRI score at baseline and at 8 weeks.
Time Points

Numeric Pain Rating Scale

Functional Rating Index

Control
Mean ± SD

PRP
Mean ± SD

Control
Mean ± SD

PRP
Mean ± SD

Baseline

2.08 ± 1.7

2.81 ± 1.8

45.37 ± 15.6

51.47 ± 15.6

8 weeks

2.72 ± 2.1

2.00 ± 2.1

44.45 ± 19.6

37.99 ± 19.6

P-value
NRS

FRI

0.03

0.02

At 6 months NRS P=0.01, FRI P= 0.01. At 1 year NRS P=0.01, FRI P= 0.01

DISCUSSION
Steroid injections have been commonly used to treat chronic lower back pain, but usually
the patient needs to have several injections done in order to experience pain reduction of at least
50%.1 PRP is a relatively new procedure that holds promise given the need for fewer procedures
and longer lasting pain relief, however, this procedure is not yet covered by health insurance
companies.5 According to Dr. Verma, an orthopedic surgeon, the average price of a single PRP
injection is $750. Patients with lower back pain often may need more than one injection in one
procedure.5 This causes a major limitation for patients since they have to pay out of pocket for
this procedure. In 2013, Hsu et al. reported that PRP is more expensive than steroid injections
when used in short-term treatment, but less expensive when used for long-term treatment.6
According to the FDA guidelines, PRP injections have not been approved by the FDA
since it does not follow the regulatory pathway that includes animal and clinical trials. However,
it has clearance from the Center for Biologics Evaluation and Research (CBER), a provider of
the FDA, to be used to mix with bone graft materials to enhance bone graft handling in
orthopedic practices. Therefore, if PRP is used outside that setting, it would be considered “off
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label” which means that the clinician can use them as long as they are well informed about the
product and its scientific rationale, as well as to maintain records of its use and side effects.7
This systematic review of three randomized controlled trials analyzed the efficacy of PRP
injections compared to steroid injections regarding long lasting back pain relief. In the study by
Singla et al.,2 the follow-up duration was very short with respect to evaluating if chronic lower
back pain could have long-lasting pain relief. A longer follow-up of at least 2 years is suggested.
In addition, this study was open-blinded, which could result in bias. In the study by Manchikanti
et al., 1 all patients continued taking drug therapy with opioids or NSAIDS, so the results might
not be due to the steroids. However, the major limitation of this study it was that the steroids
were compared to a placebo instead of PRP. In the study by Tuakli-Wosornu et al.,3 the major
limitation was the short follow-up time of the placebo group lasting 8 weeks.
Finally, regarding possible complications of PRP injections showed no complications,
only temporary pain and stiffness with 2 days post-procedure.2
CONCLUSION
Based on the information obtained from these three randomized controlled studies, both
injections demonstrated efficacy in low back pain relief. However, platelet rich plasma injections
demonstrated to be more effective over steroid injections in decreasing chronic back pain and
improving functional ability with lasting results and less adverse effects in adults in two studies.
Future studies may benefit from a longer follow up time such as 2 years. They may also benefit
from a comparison of baseline lumbar MRI versus last follow up MRI to compare if there is any
difference in regards to disc heights pre and post treatment.
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